Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2010
06/03/2010WO2010008204A3 Genes for enhancing resistance to magnaporthe oryzae and uses thereof
06/03/2010WO2009151697A9 Compositions and processes relating to human bocavirus
06/03/2010WO2009147409A3 Aquatic plant
06/03/2010WO2009143421A3 Methods for promoting fusion and reprogramming of somatic cells
06/03/2010WO2009100351A3 Delivery of rnai constructs to oligodendrocytes
06/03/2010WO2008132743A3 Production of high mannose proteins in plant culture
06/03/2010US20100138963 DNA Molecules from Maize and Methods of Use Thereof
06/03/2010US20100138962 Use of plant chromatin remodeling genes for modulating plant architecture and growth
06/03/2010US20100138961 Axmi-010, a delta-endotoxin gene and methods for its use
06/03/2010US20100138960 Nucleic Acids Encoding Anthelmintic Agents And Plants Made Therefrom
06/03/2010US20100138958 Plant Responses
06/03/2010US20100138956 Nitrogen transport metabolism
06/03/2010US20100138955 Epidermal tissue promoter derived from potato for monocots
06/03/2010US20100138954 Genes Encoding Z,Z-Farnesyl Diphosphate Synthase and A Sesquiterpene Synthase with Multiple Products and Uses Thereof
06/03/2010US20100138953 Methods for using artificial polynucleotides and compositions thereof to reduce transgene silencing
06/03/2010US20100138952 Gene promoter regulatory element analysis computational methods and their use in transgenic applications
06/03/2010US20100138951 Methods of producing haploid and doubled haploid oil palms
06/03/2010US20100138948 Transgenic plants with controlled distribution of a trait to progeny
06/03/2010US20100138947 Method for Producing Stem Cells or Stel Cell-Like Cells from Mammalian Embryos
06/03/2010US20100138946 Transgenic chickens with an inactivated endogenous gene locus
06/03/2010US20100138944 Methods of Reducing Repeat-Induced Silencing of Transgene Expression and Improved Fluorescent Biosensors
06/03/2010US20100138943 Identification of group of hypertension-susceptibility genes
06/03/2010US20100138940 Transgenic pig as a model of alzheimer's disease
06/03/2010US20100138936 Transgenic Mice and Use Thereof as an Experimental Model
06/03/2010US20100138935 Detection of cellular stress
06/03/2010US20100137641 Gene involved in quorum-sensing system of acetic acid bacterium, acetic acid bacterium bred by modification of the gene and method for production of vinegar by using the acetic acid bacterium
06/03/2010US20100137570 Host cell protein knock-out cells for production of therapeutic proteins
06/03/2010US20100137568 Transgenic plants containing soluble cell wall polysaccharides
06/03/2010US20100137564 Polypeptide of n-acetylglucosamine-6-o-sulfotransferase and dna encoding the same
06/03/2010US20100137563 Cysteine Protease Autoprocessing of Fusion Proteins
06/03/2010US20100137551 Methods and materials for the production of D-lactic acid in yeast
06/03/2010US20100137512 Polyethylene glycol/polycation block copolymers
06/03/2010US20100137415 Vector for gene therapy
06/03/2010US20100137413 Micrornaome
06/03/2010US20100137412 Lentivirus pseudotyped with influenza hemagglutinin and methods of use
06/03/2010US20100137411 Ras-mediated epigenetic silencing effectors and uses thereof
06/03/2010US20100137408 Antisense antibacterial method and compound
06/03/2010US20100137406 RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)
06/03/2010US20100137405 RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)
06/03/2010US20100137221 Peptides that interact with topoisomerase i and methods thereof
06/03/2010US20100137220 Blood sugar-modulating polypeptides
06/03/2010US20100137214 Chimeric hirudin proteins
06/03/2010US20100137210 Gastrointestinal proliferative foctor and uses thereof
06/03/2010US20100137205 Use of FGF-18 Protein, Target Proteins and Their Respective Encoding Nucleotide Sequences to Induce Cartilage Formation
06/03/2010US20100137196 Histone deacetylases, and uses related thereto
06/03/2010US20100137189 Modified globin proteins with altered electron transport pathway
06/03/2010US20100136695 Double-stranded oligonucleotides
06/03/2010US20100136694 Cone-Shaped Adapter for a Gene Gun
06/03/2010US20100136693 Mutants of Deoxycytidine Kinase Having Extended Enzymatic Activity
06/03/2010US20100136692 Plasmids and phages for homologous recombination and methods of use
06/03/2010US20100136684 Natural IgM Antibodies
06/03/2010US20100136678 Methods of diagnosis of spinal muscular atrophy and treatments thereof
06/03/2010US20100136664 Carboxin resistance gene for flammulina velutipes
06/03/2010US20100136660 Methods for producing members of specific binding pairs
06/03/2010US20100136659 Infectious cDNA Clone of North American Porcine Reproductive and Respiratory Syndrome (PPRS) Virus and Uses Thereof
06/03/2010US20100136641 Strain for butanol production with increased membrane unsaturated trans fatty acids
06/03/2010US20100136637 Recombinant microorganism having a producing ability of polylactate or its copolymers and method for preparing polyactate or its copolymers using the same
06/03/2010US20100136633 Compositions and methods for the assembly of polynucleotides
06/03/2010US20100136628 competing with natural OX40L for blocking OX40R-mediated cell signaling in the prophylaxis and/or treatment of diseases related to activated T cells
06/03/2010US20100136626 Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies
06/03/2010US20100136625 Method for the high level expression of active lymphotoxin-beta receptor immunoglobulin chimeric proteins and their purification
06/03/2010US20100136624 Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method
06/03/2010US20100136623 Mutations in ion channels
06/03/2010US20100136621 Solubility tags for the expression and purification of bioactive peptides
06/03/2010US20100136620 Soluble, stable form of hdm2, crystalline forms thereof and methods of use thereof
06/03/2010US20100136619 Expression System
06/03/2010US20100136617 Halohydrin epoxidase
06/03/2010US20100136616 Selection of Host Cells Expressing Protein at High Levels
06/03/2010US20100136581 Diagnosis and treatment of malignant neoplasms
06/03/2010US20100136577 Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene
06/03/2010US20100136575 B7-related nucleic acids and polypeptides useful for immunomodulation
06/03/2010US20100136558 Canine cd20 gene
06/03/2010US20100136548 Methods and compositions for ordering restriction fragments
06/03/2010US20100136537 Photoreceptor precursor cells
06/03/2010US20100136528 Fiat nucleic acids and proteins and uses thereof
06/03/2010US20100136526 Therapeutic Agent for Neuroblastoma Targeting ARID3b
06/03/2010US20100136524 Target protein and target gene in drug designing and screening method
06/03/2010US20100136522 Endogenous retroviruses up-regulated in prostate cancer
06/03/2010US20100136169 Novel asparaginases and uses thereof
06/03/2010US20100136113 Phytases, nucleic acids encoding them and methods for making and using them
06/03/2010US20100136101 Compositions and methods for sirna inhibition of hif-1 alpha
06/03/2010US20100136100 Removal promoters and inhibitor for apoptosis cells in vivo
06/03/2010US20100136059 Hybrid operon for expression of colonization factor (cf) antigens of enterotoxigenic escherichia coli
06/03/2010US20100136057 Virulence of streptococci
06/03/2010US20100136056 Novel insertion sites in pox vectors
06/03/2010US20100136054 Flavivirus ns1 subunit vaccine
06/03/2010US20100136052 Replication deficient influenza virus for the expression of heterologous sequences
06/03/2010US20100136039 Borrelia antigens
06/03/2010US20100136036 Unconventional antigen translated by a novel internal ribosome entry site elicits antitumor humoral immune reactions
06/03/2010US20100136033 METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATES
06/03/2010US20100136030 Antagonist ox40 antibodies and their use in the treatment of inflammatory and autoimmune diseases
06/03/2010US20100136028 Antagonists of pcsk9
06/03/2010US20100136027 Methods and Compositions for Treating Bacterial Infection
06/03/2010US20100136026 Ship Inhibition to Direct Hematopoietic Stem Cells and Induce Extramedullary Hematopoiesis
06/03/2010US20100136015 Methods and compositions for regulating iron homeostasis by modulation of bmp-6
06/03/2010US20100136014 GIPs, a Family of Polypeptides with Transcription Factor Activity that Interact with Goodpasture Antigen Binding Protein
06/03/2010US20100136011 Antibodies that bind to obm
06/03/2010US20100136009 OVR110 Antibody Compositions and Methods of Use
06/03/2010US20100136008 TACI-Fc Fusion Proteins, Methods of Making and Uses Thereof
06/03/2010US20100135996 Monoclonal antibodies and fragment thereof directed against the human anti-mullerian hormone type ii receptor (amhr-ii)
1 ... 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 ... 4023